ArticleEBioMedicine2020

A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity.

Xiaoyu Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.